Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Drug Metab Dispos
2010 Oct 01;3810:1798-805. doi: 10.1124/dmd.110.032987.
Show Gene links
Show Anatomy links
Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations.
Zhou M
,
Duan H
,
Engel K
,
Xia L
,
Wang J
.
???displayArticle.abstract???
The plasma membrane monoamine transporter (PMAT) belongs to the equilibrative nucleoside transporter family (solute carrier 29) and was alternatively named equilibrative nucleoside transporter 4. Previous studies from our laboratory characterized PMAT as a polyspecific organic cation transporter that minimally interacts with nucleosides. Recently, PMAT-mediated uptake of adenosine (a purine nucleoside) was reported, and the transporter was proposed to function as a dual nucleoside/organic cation transporter. To clarify the substrate specificity of PMAT, we comprehensively analyzed the transport activity of human PMAT toward nucleosides, nucleobases, and organic cations in heterologous expression systems under well controlled conditions. Among 12 naturally occurring nucleosides and nucleobases, only adenosine was significantly transported by PMAT. PMAT-mediated adenosine transport is saturable, pH-dependent, and membrane-potential sensitive. Under both neutral (pH 7.4) and acidic (pH 6.6) conditions, adenosine is transported by PMAT at an efficiency (V(max)/K(m)) at least 10-fold lower than that of the organic cation substrates 1-methyl-4-phenylpyridinium and serotonin. PMAT-mediated adenosine uptake rate was significantly enhanced by an acidic extracellular pH. However, the effect of acidic pH was not adenosine-specific but was common to organic cation substrates as well. Our results demonstrated that although PMAT transports adenosine, the transporter kinetically prefers organic cation substrates. Functionally, PMAT should be viewed as a polyspecific organic cation transporter rather than an archetypical nucleoside transporter.
Baldwin,
The equilibrative nucleoside transporter family, SLC29.
2004, Pubmed
Baldwin,
The equilibrative nucleoside transporter family, SLC29.
2004,
Pubmed
Baldwin,
Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes.
2005,
Pubmed
,
Xenbase
Ballarín,
Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism.
1991,
Pubmed
Barnes,
Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH.
2006,
Pubmed
,
Xenbase
Dahlin,
Expression and immunolocalization of the plasma membrane monoamine transporter in the brain.
2007,
Pubmed
Eltzschig,
HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia.
2005,
Pubmed
Engel,
Identification and characterization of a novel monoamine transporter in the human brain.
2004,
Pubmed
,
Xenbase
Engel,
Interaction of organic cations with a newly identified plasma membrane monoamine transporter.
2005,
Pubmed
Fink,
Instability of standard PCR reference genes in adipose-derived stem cells during propagation, differentiation and hypoxic exposure.
2008,
Pubmed
Fujita,
Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants.
2006,
Pubmed
Govindarajan,
Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3.
2009,
Pubmed
,
Xenbase
Gray,
The concentrative nucleoside transporter family, SLC28.
2004,
Pubmed
Griffith,
Nucleoside and nucleobase transport systems of mammalian cells.
1996,
Pubmed
Hammond,
Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1.
2004,
Pubmed
Hellsten,
Adenosine concentrations in the interstitium of resting and contracting human skeletal muscle.
1998,
Pubmed
Koepsell,
Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.
2007,
Pubmed
Kong,
Mammalian nucleoside transporters.
2004,
Pubmed
Latini,
Adenosine in the central nervous system: release mechanisms and extracellular concentrations.
2001,
Pubmed
MacLean,
Systemic hypoxia elevates skeletal muscle interstitial adenosine levels in humans.
1998,
Pubmed
Olah,
Adenosine receptors.
1992,
Pubmed
Rathbone,
Trophic effects of purines in neurons and glial cells.
1999,
Pubmed
Romanowski,
GUS and PMM1 as suitable reference genes for gene expression analysis in the liver tissue of patients with chronic hepatitis.
2008,
Pubmed
Sebastião,
Adenosine receptors and the central nervous system.
2009,
Pubmed
Visser,
Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole.
2002,
Pubmed
,
Xenbase
Ward,
Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
2000,
Pubmed
Wright,
Molecular and cellular physiology of renal organic cation and anion transport.
2004,
Pubmed
Xia,
Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells.
2007,
Pubmed
Young,
Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins.
2008,
Pubmed
Zetterström,
Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre.
1982,
Pubmed
Zhou,
Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain.
2007,
Pubmed
,
Xenbase
Zhou,
Molecular determinants of substrate selectivity of a novel organic cation transporter (PMAT) in the SLC29 family.
2007,
Pubmed
Zhou,
Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine.
2007,
Pubmed
